Prof.Yi-SunYang Taiwan

Prof.Yi-SunYang
Dr. Yi-Sun Yang is a Professor of Internal Medicine at Chung Shan Medical University and currently serves as Chair of the Department of Internal Medicine at Chung Shan Medical University Hospital, Taiwan. She is also the President of the Taichung Diabetes Shared Care Association. Dr. Yang is a board-certified specialist in Internal Medicine and Endocrinology and Metabolism. She received her MD, MSc, and PhD degrees from Chung Shan Medical University. Her clinical and research expertise focuses on diabetes care, structured diabetes education, glucose monitoring, and real-world evidence studies using large healthcare databases. She has held multiple leadership roles in diabetes care networks and national professional societies, including Secretary General of the Taiwan Diabetes Association, and has served as an expert consultant for diabetes shared care programs supported by the Taichung City Government and the Ministry of Health and Welfare. Dr. Yang has published extensively in high-impact international journals such as Diabetes Care, BMJ Open, Scientific Reports, and Frontiers in Pharmacology, and has presented her research at international conferences including the American Diabetes Association Scientific Sessions.

22 MARCH

Time Session
11:00
12:30
ESROC-KES Joint Symposium
Updates in Endocrinology: Emerging Insights into Adrenal Disorders, Muscle Health, and Endocrine Diseases
  • Pheochromocytoma: Current Concepts and Emerging Evidence
    Min Jeong ParkSouth Korea Speaker Pheochromocytoma: Current Concepts and Emerging Evidence
  • Translational Research for Developing Blood-Based Biomarkers of Sarcopenia
    Beom-Jun KimSouth Korea Speaker Translational Research for Developing Blood-Based Biomarkers of Sarcopenia
  • Anxiety in Patients with Thyroid Nodules: What Clinicians Need to Know
    Edy KorneliusTaiwan Speaker Anxiety in Patients with Thyroid Nodules: What Clinicians Need to KnowThyroid nodules are commonly encountered in endocrine practice, and while the majority are benign, the diagnostic and surveillance process often imposes a substantial psychological burden on patients. Anxiety related to fear of malignancy, uncertainty surrounding ultrasonographic findings, fine-needle aspiration results, and long-term follow-up is frequently underestimated and insufficiently addressed in routine clinical care. Emerging evidence suggests that anxiety in patients with thyroid nodules may persist even after reassurance of benign disease and can significantly affect quality of life, healthcare utilization, and decision-making preferences. Cancer-related worry is often disproportionate to the actual risk of malignancy and may be exacerbated by repeated imaging, indeterminate cytology, ambiguous terminology, and lack of clear follow-up strategies. Heightened anxiety has been associated with increased demand for diagnostic interventions and preference for aggressive management, potentially leading to overtreatment. This presentation reviews current evidence on the prevalence, determinants, and clinical consequences of anxiety among patients with thyroid nodules, integrating published literature with real-world clinical experience. Practical approaches for identifying psychological distress in outpatient settings and strategies for improving communication and expectation management will be discussed. Recognizing and addressing anxiety as an integral component of thyroid nodule care is essential for delivering holistic, patient-centred, and value-based endocrinology.
  • Impaired Fasting Glucose and Musculoskeletal Disorders
    Yi-Sun YangTaiwan Speaker Impaired Fasting Glucose and Musculoskeletal Disorders
  • Discussion
103